entrectinib
Showing 1 - 24 of 24
Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)
Active, not recruiting
- Uveal Melanoma
- PAC-1
- Entrectinib
-
Minneapolis, MinnesotaHealthPartners Institute Regions Cancer Care Center
Nov 15, 2022
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- Decitabine and Cedazuridine
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
May 25, 2022
Hepatic Insufficiency Trial in Praha 7, Miskolc, Bratislava (entrectinib)
Completed
- Hepatic Insufficiency
- entrectinib
-
Praha 7, Czechia
- +2 more
Jan 14, 2022
Cancer Medicines in Metastatic Non-small Cell Lung Cancer in
Not yet recruiting
- Non-Small Cell Lung Cancer
- lorlatinib
- +17 more
-
Oslo, NorwayPfizer Norway
Apr 17, 2023
Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)
Recruiting
- Solid Tumor
- +10 more
- Entrectinib
-
Belfast, United Kingdom
- +25 more
Mar 14, 2023
Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,
Recruiting
- Invasive Lobular Breast Carcinoma
- +2 more
- Entrectinib
- +2 more
-
Brussels, Belgium
- +9 more
May 4, 2022
NSCLC Trial in Worldwide (Entrectinib, Crizotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Entrectinib
- Crizotinib
-
Barretos, SP, Brazil
- +66 more
Jan 27, 2023
Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)
Recruiting
- Advanced Cancer
- Solid Tumor
- Alectinib
- +13 more
-
Helsinki, Uusimaa, Finland
- +2 more
Jun 8, 2022
Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)
Recruiting
- Solid Tumors
- CNS Tumors
- Entrectinib
-
Orange, California
- +38 more
Aug 24, 2022
Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Korea, Republic of, United States (Entrectinib)
Completed
- Locally Advanced Solid Tumors
- Metastatic Solid Tumors
- Entrectinib
-
Orange, California
- +9 more
Jun 7, 2021
Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)
Recruiting
- Breast Cancer
- +15 more
- Entrectinib
-
Goodyear, Arizona
- +146 more
Aug 24, 2022
Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)
Recruiting
- Solid Tumor
- Haematological Malignancy
- Alectinib
- +4 more
-
Belfast, United Kingdom
- +24 more
Jan 31, 2023
ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,
Terminated
- ALK Fusion Protein Expression
- +14 more
- Capmatinib
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 14, 2020
Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)
Recruiting
- Cancer
- +3 more
- Panitumumab
- +32 more
-
Amersfoort, Utrecht, Netherlands
- +34 more
Oct 26, 2021
Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)
Recruiting
- Solid Tumors
- Entrectinib
- +8 more
-
Daphne, Alabama
- +156 more
Jan 13, 2023
Cancers With NTRK, ROS1, or ALK Gene Fusions Trial in San Diego (Entrectinib)
No longer available
- Cancers With NTRK, ROS1, or ALK Gene Fusions
- Entrectinib
-
San Diego, California1-844-Startrk (782-7875)
Apr 24, 2019
Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)
Recruiting
- Advanced Unresectable or Metastatic Solid Malignancy
- Entrectinib
- +11 more
-
Birmingham, Alabama
- +50 more
Aug 10, 2022
Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)
Active, not recruiting
- Cancer of Unknown Primary Site
- Alectinib
- +17 more
-
Blacktown, New South Wales, Australia
- +140 more
Jan 6, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Crizotinib
- +17 more
-
Birmingham, Alabama
- +125 more
Nov 21, 2022
Advanced Solid Tumor Trial in Denver, Sarasota, Nashville (Entrectinib, Midazolam Hydrochloride)
Completed
- Advanced Solid Tumor
- Entrectinib
- Midazolam Hydrochloride
-
Denver, Colorado
- +2 more
Aug 17, 2018